2020 tables: Institutions - life sciences - corporate

The 2020 tables are based on Nature Index data from 1 January 2019 to 31 December 2019.

Table criteria

# Institution Share 2018 Share 2019 Count 2019 Change in Adjusted Share 2018-2019*
1 BGI, China 4.96 9.12 43 82.7%
2 China National Chemical Corporation (ChemChina), China 0.64 1.79 7 178.4%
3 Shanghai Blueray Biopharma Co. Ltd., China 1.00 1 N/A
4 Topchoice Group, China 0.05 0.85 9 1,462.7%
5 Insilico Medicine, China 0.73 1 N/A
6 China Shipbuilding Industry Corporation (CSIC), China 0.58 0.61 28 3.5%
7 WuXi AppTec, China 0.99 0.58 9 -42.2%
8 Biomarker Technologies Corporation, China 0.09 0.55 3 514.5%
9 Beijing Syngentech Co., LTD., China 0.13 0.50 1 297.7%
10 Nextomics Biosciences Co., Ltd., China 0.31 0.45 3 45.2%
11 3D Medicines Inc., China 0.43 0.43 1 -0.6%
12 FiberHome Technologies Group, China 0.21 0.39 8 87.8%
13 Marino Biotechnology Corp., China 0.39 1 N/A
14 Novogene Co., Ltd., China 0.95 0.34 5 -64.2%
15 Jiangsu Jiangzhong Group, China 0.18 0.34 19 87.5%
16 Dingfu Biotarget Co. Ltd., China 0.31 1 N/A
17 GrandOmics Biosciences, China 0.13 0.30 2 141.8%
18 Geneplus-Beijing Institute, China 0.60 0.29 1 -51.8%
19 Lyvgen Biopharma Co. Ltd., China 0.29 1 N/A
20 Shanghai ChemPartner Co., Ltd., China 0.28 3 N/A
21 Guangdong Wen's Nanfang Poultry Breeding Co. Ltd., China 0.25 1 N/A
21 China State Institute of Pharmaceutical Industry (CSIPI), China 0.25 1 N/A
22 Wuhan Frasergen Genetic Information Company, China 0.22 1 N/A
23 OrigiMed Co. Ltd., China 0.04 0.21 2 476.6%
24 EdiGene Inc., China 0.20 3 N/A
25 Tencent, China 0.20 1 N/A
26 Qianyang Biomedical Research Institute, China 0.20 1 N/A
27 Fosun Orinove PharmaTech Inc., China 0.26 0.19 1 -27.4%
28 Guangzhou Wolbaki Biotech Co., Ltd., China 0.17 1 N/A
29 Annoroad Gene Technology Co., Ltd., China 0.17 2 N/A
30 Qi's Academy, China 0.17 1 N/A
30 PharmaBlock Sciences (Nanjing), Inc., China 0.17 1 N/A
30 Yikon Genomics Co. Ltd., China 0.17 1 N/A
30 GenenDesign Co., Ltd., China 0.17 1 N/A
30 Palo Alto Pharmaceuticals, China 0.17 1 N/A
31 Wuxi Biortus Biosciences Co., Ltd., China 0.17 2 N/A
32 CapitalBio Corporation, China 0.12 0.16 2 36.8%
33 Beijing Ori-Gene Science and Technology Co., Ltd., China 0.15 1 N/A
34 Beijing Pangenomics Technology Co., Ltd. (Genetron Health), China 0.04 0.15 2 253.5%
35 PubBio-Tech Services Corporation, China 0.14 1 N/A
36 LipidAll Technologies Co., Ltd., China 0.13 1 N/A
36 Harbin Botai Bio-Tech Co., Ltd., China 0.13 1 N/A
36 Shanghai Sunstem Biotechnology Co., Ltd., China 0.13 1 N/A
36 National Shanghai Center for New Drug Safety Evaluation and Research, China 0.13 1 N/A
37 Tasly Holding Group Co., Ltd., China 0.11 1 N/A
37 Zangnuo Group, China 0.11 1 N/A
37 Guizhou Bailing Pharmaceutical Co., Ltd., China 0.11 1 N/A
38 Genosys, Inc., China 0.10 1 N/A
39 Sinovac Biotech Co., Ltd., China 0.18 0.09 1 -49.8%
39 Berry Genomics Co., Ltd., China 0.09 1 N/A
40 Shanghai Majorbio Bio-Pharm Technology Co., Ltd., China 0.08 1 N/A
41 Bio-Cancer Treatment International Limited (BCT), China 0.08 2 N/A
42 Gcrispr (Tianjin) Genetic Technology, China 0.08 1 N/A
42 Clarivate Analytics, China 0.08 1 N/A
42 Esquel Group, China 0.08 1 N/A
43 Beijing Compass Biotechnology Company, China 0.07 1 N/A
44 Hangzhou YITU Healthcare Technology Co. Ltd, China 0.07 1 N/A
45 Cellular Biomedicine Group, Inc., China 0.08 0.07 3 -10.5%
46 Nanjing Legend Biotechnology Co., Ltd., China 0.07 1 N/A
47 Pharchoice Therapeutics Inc., China 0.07 1 N/A
48 Zhejiang DIAN Diagnostics Co., Ltd., China 0.06 1 N/A
48 PackGene Biotech, LLC, China 0.06 1 N/A
48 Shandong Asia-pacific Highharve Organisms Science and Technology CO., LTD., China 0.06 1 N/A
49 Nowbio Biotechnology Company, China 0.06 2 N/A
50 J1 Biotech Co., Ltd., China 0.06 1 N/A
50 Zoonbio Biotechnology Co., Ltd., China 0.06 1 N/A

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.